BME:VISFood
Viscofan (BME:VIS) Valuation Check After Record 2025 Results And New Beat´30 Growth Plan
Viscofan (BME:VIS) is back on investors’ radar after reporting record 2025 revenue, EBITDA and profit, pairing those results with higher proposed shareholder payouts and a new Beat´30 plan aimed at longer term value creation.
See our latest analysis for Viscofan.
The recent earnings release, record 2025 results and the new Beat´30 plan seem to be feeding into improving momentum, with a 30 day share price return of 5.89% and a 90 day share price return of 10.63%, while the 5 year total...